Clinical Studies of Biological Response Modifiers


NIH 1994 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1993 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1993 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1992 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1992 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1991 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1990 N01 CM	Clinical Studies of Biological Response Modifiers Borden, Ernest C. / University of Wisconsin Madison
NIH 1990 N01 CM	Clinical Studies of Biological Response Modifiers Sondel, Paul M. / University of Wisconsin Madison
NIH 1989 N01 CM	Clinical Studies of Biological Response Modifiers Bordden, Ernest C. / University of Wisconsin Madison
NIH 1988 N01 CM	Clinical Studies of Biological Response Modifiers Borden, Ernest C. / University of Wisconsin Madison

Albertini, M R; Hank, J A; Schiller, J H et al. (1997) Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. Clin Cancer Res 3:1277-88